Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

BACKGROUND: Our objective was to describe the clinical course and treatment challenges in a very young patient with a pituitary adenoma due to a novel aryl hydrocarbon receptor–interacting protein (AIP) gene mutation, highlighting the limitations of somatostatin receptor immunohistochemistry to pred...

Descripción completa

Detalles Bibliográficos
Autores principales: van Santen, Selveta Sanne, Daly, Adrian F., Buchfelder, Michael, Coras, Roland, Zhao, Yining, Beckers, Albert, van der Lely, Aart Jan, Hofland, Leo J., Balvers, Rutger K., van Koetsveld, P., van den Heuvel-Eibrink, Marry Marrigje, Neggers, Sebastian Johannes Cornelis Martinus Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123570/
https://www.ncbi.nlm.nih.gov/pubmed/35602875
http://dx.doi.org/10.1016/j.aace.2021.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123570/
https://www.ncbi.nlm.nih.gov/pubmed/35602875
http://dx.doi.org/10.1016/j.aace.2021.12.003

Ejemplares similares